scholarly journals Age‐Specific Administration of Chemotherapy and Long‐Term Quality of Life in Stage II and III Colorectal Cancer Patients: A Population‐Based Prospective Cohort

2011 ◽  
Vol 16 (12) ◽  
pp. 1741-1751 ◽  
Author(s):  
Lina Jansen ◽  
Michael Hoffmeister ◽  
Jenny Chang‐Claude ◽  
Moritz Koch ◽  
Hermann Brenner ◽  
...  
2006 ◽  
Vol 42 (12) ◽  
pp. 1848-1857 ◽  
Author(s):  
Volker Arndt ◽  
Henrike Merx ◽  
Christa Stegmaier ◽  
Hartwig Ziegler ◽  
Hermann Brenner

2004 ◽  
Vol 22 (23) ◽  
pp. 4829-4836 ◽  
Author(s):  
Volker Arndt ◽  
Henrike Merx ◽  
Christa Stegmaier ◽  
Hartwig Ziegler ◽  
Hermann Brenner

Purpose Quality of life (QOL) has become an important outcome measure for patients with cancer, but long-term results from population-based studies are rare. The objective of our study was to identify specific limitations of QOL in survivors of colorectal cancer in comparison with men and women from the general population 1 year after diagnosis when acute treatment effects are expected to have declined. Patients and Methods QOL was assessed 1 year after diagnosis in a population-based cohort of 439 patients with colorectal cancer from Saarland (Germany) using the EORTC-QLC30 questionnaire. Specific functional and symptom QOL scores were compared with published reference data from the general population. Results Of 439 patients, 378 of them survived the first year after tumor diagnosis (86.1%). Of these, 309 returned the questionnaire (response rate, 81.7%). Compared with the general population, colorectal cancer patients scored their physical, role, cognitive, and global health functioning only slightly worse. More severe limitations were observed for the emotional and social functioning scales and for the symptom subscales of fatigue, dyspnea, insomnia, constipation, diarrhea, and financial difficulties. The differences regarding functional and symptom scores were predominantly found in younger age groups whereas older cancer patients and controls rated their health and QOL similarly. Conclusion Deficits in emotional and social functioning and specific limitations like fatigue, dyspnea, insomnia, constipation, diarrhea, and financial difficulties are main factors hampering the QOL among colorectal cancer patients and seem to affect predominantly younger patients.


2019 ◽  
Vol 58 (4) ◽  
pp. 398-406 ◽  
Author(s):  
L. M. Soveri ◽  
A. Lamminmäki ◽  
U. A. Hänninen ◽  
M. Karhunen ◽  
P. Bono ◽  
...  

2019 ◽  
Author(s):  
Julia Sánchez-Gundín ◽  
Cristina Martín-Sabroso ◽  
Ana M. Fernández-Carballido ◽  
D. Barreda-Hernández ◽  
Ana I. Torres-Suárez

2009 ◽  
Vol 18 (5) ◽  
pp. 547-555 ◽  
Author(s):  
Johannes Giesinger ◽  
Georg Kemmler ◽  
Verena Mueller ◽  
August Zabernigg ◽  
Beate Mayrbaeurl ◽  
...  

2016 ◽  
Vol 38 (7) ◽  
pp. 893-908 ◽  
Author(s):  
Hong-Yi Tung ◽  
Tung-Bo Chao ◽  
Yu-Hua Lin ◽  
Shu-Fen Wu ◽  
Hui-Yen Lee ◽  
...  

In this study, we sought to explore the prevalence of depression and fatigue in colorectal cancer patients during and after treatment to examine how these variables affect quality of life (QoL). In total, 170 patients with colorectal cancer participated in this study. The study population was divided into two groups: one receiving treatment and another that had finished treatment. The results showed that depression and fatigue measurements were higher in patients receiving treatment. Depression was a strong and significant predictor of QoL in both groups, whereas fatigue was not, with the exception of the symptom score. These findings underscore the importance of early detection and management of depression and fatigue during the treatment and survival stages of patients with colorectal cancer. Our findings indicate that health care professionals should provide appropriate nursing intervention to decrease depression and fatigue and enhance patient QoL.


Sign in / Sign up

Export Citation Format

Share Document